DFMG reverses proliferation and migration of vascular smooth muscle cells induced by co-culture with injured vascular endothelial cells via suppression of the TLR4-mediated signaling pathway

Cong,Li; Zhang,Yong; Huang,He; Cao,Jianguo; Fu,Xiaohua

doi:10.3892/mmr.2018.8635

DFMG reverses proliferation and migration of vascular smooth muscle cells induced by co-culture with injured vascular endothelial cells via suppression of the TLR4-mediated signaling pathway

Authors:
- Li Cong
- Yong Zhang
- He Huang
- Jianguo Cao
- Xiaohua Fu
View Affiliations

Affiliations: Medical College, Hunan Normal University, Changsha, Hunan 410013, P.R. China, Department of Pathology, Maternal and Child Health Hospital of Hunan Province, Changsha, Hunan 410008, P.R. China
Published online on: February 26, 2018 https://doi.org/10.3892/mmr.2018.8635
Pages: 5692-5699
Copyright: © Cong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

7-Difluoromethoxy-5,4'-dimethoxy-genistein (DFMG) is a novel chemical compound synthesized using genistein. Previous studies have indicated that DFMG can reverse the apoptosis of vascular endothelial cells (VECs) by regulating the mitochondrial apoptosis pathway. The present study aimed to investigate the activity and molecular mechanism underlying DFMG‑mediated protection of vascular smooth muscle cell (VSMCs) using a non‑contact co‑culture model established by using Transwell insert. Secretion of interleukin‑6 (IL‑6) and tumor necrosis factor‑α (TNF‑α) were measured by ELISA. Proliferation and migration of VSMCs were assessed using a Cell Counting kit‑8 and wound healing assays, respectively. Toll‑like receptor 4 (TLR4) mRNA and protein levels were detected by reverse transcription-quantitative polymerase chain reaction and western blotting analyses, respectively. In the present study, lysophosphatidylcholine (LPC) significantly increased the secretion of IL‑6 and TNF‑α in VECs. VECs treated with LPC markedly increased proliferation and migration of VSMCs, which were inhibited by DFMG. Transfection of either TLR4 short hairpin RNA (shRNA) or TLR4 cDNA in VECs inhibited and increased proliferation and migration of VSMCs, respectively. Furthermore, transfection of VECs with TLR4 shRNA suppressed the proliferation and migration of VSMCs induced by co‑culture with injured VECs, which was further enhanced by treatment with DFMG. By contrast, transfection of VECs with TLR4 cDNA enhanced proliferation and migration of VSMCs and this effect was inhibited by treatment with DFMG. Taken together, the results of the present study demonstrated that DFMG can reverse proliferation and migration of VSMCs induced by co‑culture with injured VECs via suppression of the TLR4‑mediated signaling pathway.

View Figures

View References

1	Heidari M, Mandato CA and Lehoux S: Vascular smooth muscle cell phenotypic modulation and the extracellular matrix. Artery Res. 9:14–18. 2015. View Article : Google Scholar
2	Lin X, He Y, Hou X, Zhang Z, Wang R and Wu Q: Endothelial cells can regulate smooth muscle cells in contractile phenotype through the miR-206/ARF6&NCX1/exosome axis. PLoS One. 11:e01529592016. View Article : Google Scholar : PubMed/NCBI
3	Afzal TA, Luong LA, Chen D, Zhang C, Yang F, Chen Q, An W, Wilkes E, Yashiro K, Cutillas PR, et al: NCK associated protein 1 modulated by miRNA-214 determines vascular smooth muscle cell migration, proliferation, and neointima hyperplasia. J Am Heart Assoc. 5(pii): e0046292016. View Article : Google Scholar : PubMed/NCBI
4	Ostriker A, Horita HN, Poczobutt J, Weiser-Evans MC and Nemenoff RA: Vascular smooth muscle cell-derived transforming growth factor-β promotes maturation of activated, neointima lesion-like macrophages. Arterioscler Thromb Vasc Biol. 34:877–886. 2014. View Article : Google Scholar : PubMed/NCBI
5	Owens GK, Kumar MS and Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 84:767–801. 2004. View Article : Google Scholar : PubMed/NCBI
6	Gimbrone MA Jr and García-Cardeña G: Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 118:620–636. 2016. View Article : Google Scholar : PubMed/NCBI
7	Ding H, Li D, Zhang Y, Zhang T, Zhu H, Xu T, Luo Y and Wang C: Luteolin inhibits smooth muscle cell migration and proliferation by attenuating the production of Nox4, p-Akt and VEGF in endothelial cells. Curr Pharm Biotechnol. 14:1009–1015. 2014. View Article : Google Scholar : PubMed/NCBI
8	Xia Y, Bhattacharyya A, Roszell EE, Sandig M and Mequanint K: The role of endothelial cell-bound Jagged1 in Notch3-induced human coronary artery smooth muscle cell differentiation. Biomaterials. 33:2462–2472. 2012. View Article : Google Scholar : PubMed/NCBI
9	Zhou J, Li YS, Nguyen P, Wang KC, Weiss A, Kuo YC, Chiu JJ, Shyy JY and Chien S: Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: Role of shear stress. Circ Res. 113:40–51. 2013. View Article : Google Scholar : PubMed/NCBI
10	Li Y, Guo Y, Chen Y, Wang Y, You Y, Yang Q, Weng X, Li Q, Zhu X, Zhou B, et al: Establishment of an interleukin-1β-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis. Mol Med Rep. 12:1665–1676. 2015. View Article : Google Scholar : PubMed/NCBI
11	Satoh S, Yada R, Inoue H, Omura S, Ejima E, Mori T, Takenaka K, Kawamura N, Numaguchi K, Mori E, et al: Toll-like receptor-4 is upregulated in plaque debris of patients with acute coronary syndrome more than Toll-like receptor-2. Heart Vessels. 31:1–5. 2016. View Article : Google Scholar : PubMed/NCBI
12	Roshan MH, Tambo A and Pace NP: The role of TLR2, TLR4, and TLR9 in the pathogenesis of atherosclerosis. Int J Inflam. 2016:15328322016. View Article : Google Scholar : PubMed/NCBI
13	Lim S and Park S: Role of vascular smooth muscle cell in the inflammation of atherosclerosis. BMB Rep. 47:1–7. 2014. View Article : Google Scholar : PubMed/NCBI
14	Xing S, Zheng F, Zhang W, Wang D and Xing Q: Relationship between toll-like receptor 4 levels in aorta and severity of atherosclerosis. J Int Med Res. 42:958–965. 2014. View Article : Google Scholar : PubMed/NCBI
15	Kapelouzou A, Giaglis S, Peroulis M, Katsimpoulas M, Moustardas P, Aravanis CV, Kostakis A, Karayannakos PE and Cokkinos DV: Overexpression of toll-like receptors 2, 3, 4 and 8 is correlated to the vascular atherosclerotic process in the hyperlipidemic rabbit model: The effect of statin treatment. J Vasc Res. 54:156–169. 2017. View Article : Google Scholar : PubMed/NCBI
16	Tang YL, Jiang JH, Wang S, Liu Z, Tang XQ, Peng J, Yang YZ and Gu HF: TLR4/NF-κB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice. PLoS One. 10:e01236852015. View Article : Google Scholar : PubMed/NCBI
17	Pahwa R, Nallasamy P and Jialal I: Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx. J Diabetes Complications. 30:563–572. 2016. View Article : Google Scholar : PubMed/NCBI
18	Wang XQ, Wan HQ, Wei XJ, Zhang Y and Qu P: CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice. Mol Med Rep. 14:49–56. 2016. View Article : Google Scholar : PubMed/NCBI
19	Yang X, Coriolan D, Murthy V, Schultz K, Golenbock DT and Beasley D: Proinflammatory phenotype of vascular smooth muscle cells: Role of efficient Toll-like receptor 4 signaling. Am J Physiol Heart Circ Physiol. 289:H1069–H1076. 2005. View Article : Google Scholar : PubMed/NCBI
20	Jiang D, Li D, Cao L, Wang L, Zhu S, Xu T, Wang C and Pan D: Positive feedback regulation of proliferation in vascular smooth muscle cells stimulated by lipopolysaccharide is mediated through the TLR 4/Rac1/Akt pathway. PLoS One. 9:e923982014. View Article : Google Scholar : PubMed/NCBI
21	Li H, Xu H and Liu S: Toll-like receptors 4 induces expression of matrix metalloproteinase-9 in human aortic smooth muscle cells. Mol Biol Rep. 38:1419–1423. 2011. View Article : Google Scholar : PubMed/NCBI
22	Zhou X, Yuan L, Zhao X, Hou C, Ma W, Yu H and Xiao R: Genistein antagonizes inflammatory damage induced by β-amyloid peptide in microglia through TLR4 and NF-κB. Nutrition. 30:90–95. 2014. View Article : Google Scholar : PubMed/NCBI
23	Ma W, Ding B, Yu H, Yuan L, Xi Y and Xiao R: Genistein alleviates β-amyloid-induced inflammatory damage through regulating Toll-like receptor 4/nuclear factor κB. J Med Food. 18:273–279. 2015. View Article : Google Scholar : PubMed/NCBI
24	Liu F, Cao JG, Li C, Tan JS and Fu XH: Protective effects of 7-difluoromethyl-5,4′-dimethoxygenistein against human aorta endothelial injury caused by lysophosphatidyl choline. Mol Cell Biochem. 363:147–155. 2012. View Article : Google Scholar : PubMed/NCBI
25	Liu S, Li L, Zhang J, Huang H, Yang S, Ren C, Fu X and Zhang Y: 7-difluoromethyl-5, 4′-dimethoxygenistein reverses LPC-induced apoptosis of HUVE-12 cells through regulating mitochondrial apoptosis pathway. Curr Signal Transd Ther. 9:50–58. 2014. View Article : Google Scholar
26	Zhang Y, Li L, You J, Cao J and Fu X: Effect of 7-difluoromethyl-5, 4′-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE(−/−) mice induced by a cholesterol-rich diet. Drug Des Devel Ther. 7:233–242. 2013. View Article : Google Scholar : PubMed/NCBI
27	Fu XH, Wang L, Zhao H, Xiang HL and Cao JG: Synthesis of genistein derivatives and determination of their protective effects against vascular endothelial cell damages caused by hydrogen peroxide. Bioorg Med Chem Lett. 18:513–517. 2008. View Article : Google Scholar : PubMed/NCBI
28	Chen L, DeWispelaere A, Dastvan F, Osborne WR, Blechner C, Windhorst S and Daum G: Smooth muscle-alpha actin inhibits vascular smooth muscle cell proliferation and migration by inhibiting Rac1 activity. PLoS One. 11:e01557262016. View Article : Google Scholar : PubMed/NCBI
29	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
30	Cibor D, Domagala-Rodacka R, Rodacki T, Jurczyszyn A, Mach T and Owczarek D: Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J Gastroenterol. 22:1067–1077. 2016. View Article : Google Scholar : PubMed/NCBI
31	Sevastou I, Kaffe E, Mouratis MA and Aidinis V: Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes. Biochim Biophys Acta. 1831:42–60. 2013. View Article : Google Scholar : PubMed/NCBI
32	Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Hólm H, Ding EL, Johnson T, et al: Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study. Lancet. 380:572–580. 2012. View Article : Google Scholar : PubMed/NCBI
33	Wang X, Hu G, Gao X, Wang Y, Zhang W, Harmon EY, Zhi X, Xu Z, Lennartz MR, Barroso M, et al: The induction of yes-associated protein expression after arterial injury is crucial for smooth muscle phenotypic modulation and neointima formation. Arterioscler Thromb Vasc Biol. 32:2662–2669. 2012. View Article : Google Scholar : PubMed/NCBI
34	Luo H, Wang J, Qiao C, Ma N, Liu D and Zhang W: Pycnogenol attenuates atherosclerosis by regulating lipid metabolism through the TLR4-NF-κB pathway. Exp Mol Med. 47:e1912015. View Article : Google Scholar : PubMed/NCBI
35	Lee GL, Wu JY, Tsai CS, Lin CY, Tsai YT, Lin CS, Wang YF, Yet SF, Hsu YJ and Kuo CC: TLR4-activated MAPK-IL-6 axis regulates vascular smooth muscle cell function. Int J Mol Sci. 17(pii): E13942016. View Article : Google Scholar : PubMed/NCBI
36	Hosseini H, Li Y, Kanellakis P, Tay C, Cao A, Liu E, Peter K, Tipping P, Toh BH, Bobik A and Kyaw T: Toll-like receptor (TLR)4 and MyD88 are essential for atheroprotection by peritoneal B1a B cells. J Am Heart Assoc. 5(pii): e0029472016. View Article : Google Scholar : PubMed/NCBI
37	Ding Y, Subramanian S, Montes VN, Goodspeed L, Wang S, Han C, Teresa AS III, Kim J, O'Brien KD and Chait A: Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor deficient mice. Arterioscler Thromb Vasc Biol. 32:1596–1604. 2012. View Article : Google Scholar : PubMed/NCBI